Bhargav D Sanketi, PhD
How tissues build themselves. How they break. How to rewrite them.
Tissue phenotypes are not determined by genotype alone.
Tissue states emerge from interactions among cell-intrinsic programs, the local microenvironment, and systemic physiology.
Tissues move deliberately between states to accomplish goals. They build during morphogenesis, repair after injury, and drift in disease and age.
Mechanical, signaling, transcriptional, metabolic, and epigenetic mechanisms drive tissue state reprogramming across development, aging, and therapy.
I have spent ten years learning to read those decisions and rewrite them. I read tissue state with single cell and spatial genomics, lineage tracing, and imaging. I rewrite it with protein, gene, and cell based tools.
The circuits that build an organ can be redeployed to restore it.
Cornell University, PhD thesis2017 to 2023
Building tissues
I asked how the gut gets its shape.
The mammalian intestine loops and layers itself early, and when that goes wrong it causes congenital malformation and metabolic disease. We built tools to measure and move mechanical forces inside a living embryo. We found that rotation starts when local mechanical feedback amplifies the body plan. An organ can begin to build itself from a local source of asymmetry.
Then we built a single cell atlas of the developing intestine and traced the origin of its fat absorption machinery. Villus myofibroblasts turned out to be the progenitors of gut lymphatic musculature, in the embryo and in the adult.
Developmental programs are modular. They get reused far beyond the organ that first deploys them.
Papers and preprints
- Morphogenesis of the vertebrate intestine: from form to function
- A non-canonical role for Notch3 in building the intestinal lymphatic niche
- Villus myofibroblasts are developmental and adult progenitors of mammalian gut lymphatic musculature
- Pitx2 patterns an accelerator-brake mechanical feedback through latent TGFβ to rotate the gut
- The asymmetric Pitx2 gene regulates gut muscular-lacteal development and protects against fatty liver disease
In preparation
- Spatiotemporal reconstruction of intestinal lymphatic heterogeneity
- Umbilical origin of the ventral body wall
Altos Labs, Senior Scientist2023 to 2026
Breaking tissues
I turned to how tissues fail.
Across more than forty human age associated diseases, cells near injury drift toward a mesenchymal state. We defined that drift and showed partial reprogramming reverses it.
Reprogramming rejuvenates cells, but left running it erases their identity and forms tumors. We separated the two. The chromatin activity that rejuvenates can be uncoupled from the identity loss. That makes epigenetic reprogramming safer to pursue as a medicine.
We also showed that cell identity factors reverse state drift and restore function in aging and diseased muscle and liver in live animals.
Fibrosis, cancer, and aging are miscued state transitions. The circuitry that builds an organ can be redirected to restore one.
Papers and preprints
- Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming
- Visualizing the epigenetic landscape of aging and cellular reprogramming: optimized ATAC-see for cells and tissues
In preparation
- Uncoupling chromatin rejuvenation from dedifferentiation during partial reprogramming
- Respecifying cell identity in the liver
- Respecifying cell identity in muscle
Co-founder at stealthNow
Enhancing tissues
The secretome is an especially tractable entry point into tissue state, and the one that translates most directly to the clinic.
Recognition
- Rising Star in Bioengineering, Princeton, 2023
- Altos Above and Beyond Award, 2024
- North American National 3MT Winner, Council of Graduate Schools, 2022
- Birnstiel Award honourable mention, IMP Austria, 2023
- Presidential Life Science Fellowship, Cornell, 2017
Co-chair of the Gordon Research Seminar on Vascular Cell Biology in 2025.
Taught and mentored at Cornell and Ithaca College, including through the HHMI CHAMPS program.